XGN · Company research
Exagen Inc. Common Stock (XGN): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 8.19 | $200,565,922.7 | 175977922.7 | — | — | — | 10.0579671380572689 | 16.4182975360183366 | 58.21942603773584905613 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.